Found: 6
Select item for more details and to access through your institution.
A phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed or relapsed/refractory multiple myeloma: Final analysis of second dose‐expansion cohort.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 4, p. 428, doi. 10.1002/ajh.26088
- By:
- Publication type:
- Article
A Phase II Study of Higher Dose Weekly Topotecan in Relapsed Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 3, p. 187, doi. 10.1016/j.cllc.2011.03.016
- By:
- Publication type:
- Article
A Randomized, Open-Label Phase 2 Study of the CXCR4 Inhibitor LY2510924 in Combination with Sunitinib Versus Sunitinib Alone in Patients with Metastatic Renal Cell Carcinoma (RCC).
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Phase II Study with Lead-In Safety Cohort of 5-Fluorouracil, Oxaliplatin, and Lapatinib in Combination with Radiation Therapy as Neoadjuvant Treatment for Patients with Localized HER2-Positive Esophagogastric Adenocarcinomas.
- Published in:
- Oncologist, 2017, v. 22, n. 10, p. 1152, doi. 10.1634/theoncologist.2017-0186
- By:
- Publication type:
- Article
A Phase II Trial Evaluating the Safety of Rapid Infusion of Ofatumumab in Patients with Previously Treated Chronic Lymphocytic Leukemia.
- Published in:
- Oncologist, 2017, v. 22, n. 10, p. 1156, doi. 10.1634/theoncologist.2017-0236
- By:
- Publication type:
- Article
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 5, p. 966, doi. 10.1002/cncr.34016
- By:
- Publication type:
- Article